Patient Attitudes Toward Artificial Intelligence in Cancer Care: Scoping Review
Patient:innen-Einstellungen gegenüber künstlicher Intelligenz in der Krebsversorgung: Scoping Review
JMIR Cancer · 2025-08-22 · 11 · e74010-e74010
DOI: 10.2196/74010 ↗Auf einen Blick
19 Studien zeigen: Menschen mit Krebs befürworteten künstliche Intelligenz meist als ärztlich angeleitetes Werkzeug. Genannt wurden auch Bedenken zu Entpersonalisierung, Behandlungsbias und Datensicherheit.
Fragestellung
Wie stehen erwachsene Patient:innen mit Krebs zur Integration künstlicher Intelligenz in ihre Versorgung?
Methode
Scoping Review nach PRISMA-ScR; Suche in MEDLINE, Embase, PsycINFO und CINAHL bis 1. Februar 2025.
Ergebnisse
1240 Zitate gesichtet, 19 Studien eingeschlossen, 2114 Patient:innen aus 15 Ländern. 9/19 Studien waren quantitativ. Akzeptanz war höher bei ärztlicher Anleitung; Vertrauen hing von Arzt-Empfehlung und Vertrautheit ab.
Einschränkungen
Patient:innen mit metastasierter Erkrankung waren unterrepräsentiert; dadurch begrenzte Einblicke in diese Gruppe.
Schlussfolgerung der Autor:innen
Die Übersichtsarbeit liefert die erste Synthese zu Einstellungen von Patient:innen zu künstlicher Intelligenz über alle Krebsarten hinweg und hebt patientenspezifische Bedenken hervor.
Kernaussagen
- Akzeptanz stieg, wenn KI ärztlich angeleitet eingesetzt wurde
- Bedenken: Entpersonalisierung, Behandlungsbias, Datensicherheit
- Metastasierte Patient:innen waren in den Studien unterrepräsentiert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
At a glance
Scoping Review in JMIR Cancer, published online on 2025-08-22. Written by Daniel Hilbers and 3 co-authors. Institution: Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. Major MEDLINE topics: Artificial Intelligence, Neoplasms, Attitude to Health. Cited 15 times so far (Crossref); 54 references. The full text is freely available in PubMed Central.
Topics: Künstliche Intelligenz in der Pflege, Onkologische Pflege
Abstract (original language)
Background
Artificial intelligence is reshaping cancer care, but little is known about how people with cancer perceive its integration into their care. Understanding these perspectives is essential to ensuring artificial intelligence adoption aligns with patient needs and preferences while supporting a patient-centered approach.
Objective
The aim of this study is to synthesize existing literature on patient attitudes toward artificial intelligence in cancer care and identify knowledge gaps that can inform future research and clinical implementation.
Methods
A scoping review was conducted following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. MEDLINE, Embase, PsycINFO, and CINAHL were searched for peer-reviewed primary research studies published until February 1, 2025. The Population-Concept-Context framework guided study selection, focusing on adult patients with cancer and their attitudes toward artificial intelligence. Studies with quantitative or qualitative data were included. Two independent reviewers screened studies, with a third resolving disagreements. Data were synthesized into tabular and narrative summaries.
Results
Our search yielded 1240 citations, of which 19 studies met the inclusion criteria, representing 2114 patients with cancer across 15 countries. Most studies used quantitative methods (9/19, 47%) such as questionnaires or surveys. The most studied cancers were melanoma (375/2114, 17.7%), prostate (n=323, 15.3%), breast (n=263, 12.4%), and colorectal cancer (n=251, 11.9%). Although patients with cancer generally supported artificial intelligence when used as a physician-guided tool (9/19, 47%), concerns about depersonalization, treatment bias, and data security highlighted challenges in implementation. Trust in artificial intelligence (10/19, 53%) was shaped by physician endorsement and patient familiarity, with greater trust when artificial intelligence was physician-guided. Geographic differences were observed, with greater artificial intelligence acceptance in Asia, while skepticism was more prevalent in North America and Europe. Additionally, patients with metastatic cancer (99/2114, 5%) were underrepresented, limiting insights into artificial intelligence perceptions in this population.
Conclusions
This scoping review provides the first synthesis of patient attitudes toward artificial intelligence across all cancer types and highlights concerns unique to patients with cancer. Clinicians can use these findings to enhance patient acceptance of artificial intelligence by positioning it as a physician-guided tool and ensuring its integration aligns with patient values and expectations.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Supportive Care, BC Cancer Agency, Vancouver, BC, Canada.
- Department of Psychiatry, University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 0A6, Canada, 1 604 822 2421.
ORCID profiles: Daniel Hilbers, Navid Nekain, Alan Bates, John-Jose Nunez
Cite
APA
Hilbers, D., Nekain, N., Bates, A., & Nunez, J. J. (2025). Patient Attitudes Toward Artificial Intelligence in Cancer Care: Scoping Review. JMIR Cancer, 11, e74010-e74010. https://doi.org/10.2196/74010
Vancouver
Hilbers D, Nekain N, Bates A, Nunez JJ. Patient Attitudes Toward Artificial Intelligence in Cancer Care: Scoping Review. JMIR Cancer. 2025;11:e74010-e74010. doi:10.2196/74010
BibTeX
@article{Hilbers2025,
author = {Hilbers, Daniel and Nekain, Navid and Bates, Alan and Nunez, John-Jose},
title = {Patient Attitudes Toward Artificial Intelligence in Cancer Care: Scoping Review},
journal = {JMIR Cancer},
year = {2025},
volume = {11},
pages = {e74010--e74010},
doi = {10.2196/74010}
}
EUVIMED